Eleven outstanding faculty members were named recipients of the 2017 Dean’s Excellence Awards, an honor recognizing exceptional contributions made by School of Medicine faculty in service, teaching, research, diversity enhancement and mentorship.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
The five-year grant from the NHLBI to the labs of Jennifer and David Pollock also includes a third project at the University of Utah, bringing together three highly successful research entities.
Knowledge from this study and others may help physicians boost healing and prevent heart failure in patients after a heart attack.
The UAB Health Disparities Research Symposium highlights the health disparities work of undergraduate, graduate, faculty and community investigators in basic science, clinical research, behavioral and social science, and community-based research.
A multidisciplinary research team at UAB looks to address obesity as it is genetically passed from mother to child.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
These leaders represent the next generation of cardiologists who are working to educate their colleagues, conduct research on new and novel strategies to advance cardiovascular care, and innovate the unique aspects of the cardiology specialty.
Twelve School of Medicine faculty were recently honored as winners of the UAB Graduate Dean's Excellence in Mentorship Award.